Answer
The most common adverse reactions to burosumab in clinical trials in adults with X-linked hypophosphataemia were back pain (23%), headache (21%), tooth infection (19%), decreased vitamin D (15%), restless legs syndrome (13%), muscle spasms (12%) and dizziness (11%).
Sources for this answer
- Crysvita solution for subcutaneous injectionKyowa Kirin Ltd · emc · SmPC §4.8 Undesirable effects · Version 13Document updated
Sources checked